The College of Nanoscale Science and Engineering (CNSE) of the
University at Albany and Long Island-based Applied DNA Sciences,
Inc. (OTCBB: APDN) today announced a partnership to enable
nanotechnology-driven innovations that would play a critical role
in preventing the counterfeiting of computer chips -- a
collaboration in the groundbreaking area of "nanosecurity" that
initially targets the $20 billion defense industry chip market and
has the potential to impact nanoelectronics and aerospace markets
well in excess of $300 billion.
Through joint research and development at CNSE's Albany NanoTech
Complex, CNSE and APDN will accelerate the development of APDN's
SigNature DNA® product. This will include the integration of new
methods for DNA deposition on nanoelectronics wafers and computer
chips both prior to, and including, final packaging to ensure the
integrity and security of processed wafers.
The partnership between CNSE and APDN will support research,
development and deployment of authentication protocols and
procedures in established process flows, including CMOS, MEMS,
photonics, and other device derivatives, as well as advanced
packaging technologies, such as 3-dimensional wafer-to-wafer and
die-on-wafer. When realized, these advances would enable
comprehensive supply chain protection well into the foreseeable
future.
The collaboration comes on the heels of the enacting of the 2012
National Defense Authorization Act. This law will significantly
strengthen protections against the wave of counterfeit electronic
parts coming into the defense supply system by requiring that
military suppliers and government agencies create and implement
counterfeit detection and avoidance systems, among many other
strict anti-counterfeiting provisions. These new mandates could be
enabled through a CNSE-APDN partnership.
And while the spotlight is justifiably on protecting the defense
supply chain, the private sector would also reap significant and
immediate rewards from CNSE-APDN efforts.
"It is critical that nanotechnology research and development is
done right here in the U.S.," said U.S. Senator Kirsten Gillibrand.
"The partnership between the College of Nanoscale Science and
Engineering and Applied DNA Sciences on Long Island will help keep
our country competitive and combat nanochip counterfeiting."
Dr. James A. Hayward, President and CEO of Applied DNA Sciences,
said, "With this partnership between the UAlbany NanoCollege and
APDN, we create the field of 'nanosecurity.' Both entities
contribute leading-edge technology and proven success in its
commercialization. We are confident of results and in our capacity
for near-term deployment."
Dean Fuleihan, CNSE Executive Vice President for Strategic
Partnerships, said, "The UAlbany NanoCollege is delighted to enter
into this partnership with Applied DNA Sciences to enable
innovative anti-counterfeiting technology that is vital to
protecting American troops and U.S. military interests, both at
home and abroad. This collaboration will accelerate research,
development and commercialization to ensure the security and
integrity of computer chips that drive our nation's most advanced
weaponry and intelligence systems, and further demonstrates the
success of public-private partnerships in positioning CNSE and New
York state as a hub for 21st century military technologies driven
by nanotechnology know how."
The APDN system marks computer chips with uncopyable DNA codes,
which can then be used to authenticate the originality of chips
anywhere along the supply chain. The APDN technology can not only
enhance inspection, but also goes much further to forensically
verify originality, using botanical DNA to create "tags" to mark
the product in a unique way.
As part of the collaboration, CNSE and APDN intend to establish
a joint technology development partnership model -- engaging
nanoelectronics device fabricators, leading aerospace and defense
system integration companies, and state and federal government
agencies -- to further advance the implementation of counterfeit
protection measures. CNSE recently submitted a technology
development proposal in partnership with APDN and other leading
nanoelectronics companies in response to a Broad Agency
Announcement issued by the Intelligence Advanced Research Projects
Activity (IARPA), which invests in technology programs that have
the potential to provide our nation with an overwhelming
intelligence advantage over future adversaries.
About CNSE. The UAlbany CNSE is the first
college in the world dedicated to education, research, development
and deployment in the emerging disciplines of nanoscience,
nanoengineering, nanobioscience and nanoeconomics. With more than
$14 billon in high-tech investments, CNSE represents the world's
most advanced university-driven research enterprise, offering
students a one-of-a-kind academic experience and providing over 300
corporate partners with access to an unmatched ecosystem for
leading-edge R&D and commercialization of nanoelectronics and
nanotechnology innovations.
CNSE's footprint spans upstate New York, including its Albany
NanoTech Complex, an 800,000-square-foot megaplex with the only
fully-integrated, 300mm wafer, computer chip pilot prototyping and
demonstration line within 85,000 square feet of Class 1 capable
cleanrooms. More than 2,600 scientists, researchers, engineers,
students and faculty work here, from companies including IBM,
Intel, GlobalFoundries, SEMATECH, Samsung, TSMC, Toshiba, Applied
Materials, Tokyo Electron, ASML and Novellus Systems.
An expansion now underway, part of which will house the world's
first Global 450mm Consortium, will add nearly 500,000 square feet
of next-generation infrastructure, an additional 50,000 square feet
of Class 1 capable cleanrooms, and more than 1,000 scientists,
researchers and engineers from CNSE and global corporations.
In addition, CNSE's Solar Energy Development Center in Halfmoon
provides a prototyping and demonstration line for next-generation
CIGS thin-film solar cells. CNSE's Smart Systems Technology and
Commercialization Center of Excellence (STC) in Rochester offers
state-of-the-art capabilities for MEMS fabrication and packaging.
CNSE also co-founded and manages operations at the Computer Chip
Commercialization Center at SUNYIT in Utica and is a co-founder of
the Nanotechnology Innovation and Commercialization Excelerator in
Syracuse. For information, visit www.cnse.albany.edu.
About APDN. APDN sells patent-protected
DNA security solutions to protect products, brands and intellectual
property from counterfeiting and diversion. SigNature DNA is a
botanical mark used to authenticate products in a unique manner
that essentially cannot be copied, and provide a forensic chain of
evidence that can be used to prosecute perpetrators. To learn more,
go to www.adnas.com where APDN routinely posts all press
releases.
The statements made by APDN may be forward-looking in nature.
Forward-looking statements describe APDN's future plans,
projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many
of which are beyond the control of APDN. Actual results could
differ materially from those projected due to our short operating
history, limited financial resources, limited market acceptance,
market competition and various other factors detailed from time to
time in APDN's SEC reports and filings, including our Annual Report
on Form 10-K, filed on December 8, 2011 and our subsequent
quarterly reports on Form 10-Q. APDN undertakes no obligation to
update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to
reflect the occurrence of unanticipated events.
Contact: Steve Janack Vice President for Marketing and
Communications CNSE (phone) 518-956-7322 (e-mail) Email Contact
Mitchell Miller Director of Communications Applied DNA Sciences,
Inc. (phone) 917-573-3373 (e-mail) Email Contact
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024